Cargando…

Intrapericardial carboplatin in the management of malignant pericardial effusion in breast cancer: a pilot study

PURPOSE: Malignant pericarditis is observed in 5.1–7.0% of all cases of acute pericarditis, and malignant pericardial effusion (MPE) can lead to cardiac tamponade in the later stages of cancer. Breast cancer is the second most common primary cancer associated with MPE, but the efficacy and safety of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kotake, Mie, Imai, Hisao, Kaira, Kyoichi, Fujisawa, Tomomi, Yanagita, Yasuhiro, Minato, Koichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6682572/ https://www.ncbi.nlm.nih.gov/pubmed/31250155 http://dx.doi.org/10.1007/s00280-019-03897-0

Ejemplares similares

Management of Lung Cancer-Associated Malignant Pericardial Effusion with Intrapericardial Administration of Carboplatin: A Retrospective Study
por: Imai, Hisao, et al.
Publicado: (2021)

Controlling malignant pericardial effusion by intrapericardial carboplatin administration in patients with primaryon-small-cell lung cancer
por: Moriya, T, et al.
Publicado: (2000)

Voluminous Intrapericardial Lipoma Mimicking Pericardial Effusion
por: Prado de Morais, Fabíola, et al.
Publicado: (2020)

A randomised trial of intrapericardial bleomycin for malignant pericardial effusion with lung cancer (JCOG9811)
por: Kunitoh, H, et al.
Publicado: (2009)

Unusual intrapericardial pressure pattern in localized pericardial effusion
por: Yalonetsky, Sergey, et al.
Publicado: (2020)

Post‐progression survival is highly linked to overall survival in patients with non‐small‐cell lung cancer harboring sensitive EGFR mutations treated with first‐line epidermal growth factor receptor‐tyrosine kinase inhibitors
por: Imai, Hisao, et al.
Publicado: (2019)

Intrapericardial bevacizumab safely and effectively treats malignant pericardial effusion in advanced cancer patients
por: Chen, Dawei, et al.
Publicado: (2016)

Clinical significance of post‐progression survival in lung cancer
por: Imai, Hisao, et al.
Publicado: (2017)

Clinical Significance of the Relationship between Progression-Free Survival or Postprogression Survival and Overall Survival in Patients with Extensive Disease-Small-Cell Lung Cancer Treated with Carboplatin plus Etoposide
por: Imai, Hisao, et al.
Publicado: (2016)

Intrapericardial Doppler Flow Signals in a Patient with Postsurgical Pericardial Effusion
por: Mancuso, Luigi, et al.
Publicado: (2017)

Prolonged Drainage and Intrapericardial Bleomycin Administration for Cardiac Tamponade Secondary to Cancer-Related Pericardial Effusion
por: Numico, Gianmauro, et al.
Publicado: (2016)

Topotecan monotherapy for the treatment of relapsed small cell lung cancer in elderly patients: A retrospective analysis
por: Imai, Hisao, et al.
Publicado: (2018)

Sustained response of malignant pericardial effusion to intrapericardial bevacizumab in an advanced lung cancer patient: a case report and literature review
por: Chen, Dawei, et al.
Publicado: (2015)

The efficacy and safety of complete pericardial drainage by means of intrapericardial fibrinolysis for the prevention of complications of pericardial effusion: a systematic review protocol
por: Kakia, Aloysious, et al.
Publicado: (2016)

Post-Progression Survival Is Strongly Associated with Overall Survival in Patients Exhibiting Postoperative Relapse of Non-Small-Cell Lung Cancer Harboring Sensitizing EGFR Mutations
por: Imai, Hisao, et al.
Publicado: (2021)

Effects of intrapericardial administration after catheter drainage on malignant pericardial effusion in non‐small cell lung cancer: A real‐world study
por: Wei, Jingwen, et al.
Publicado: (2023)

Pericardial Window Formation Complicated by Intrapericardial Diaphragmatic Hernia
por: Docekal, Jeremy, et al.
Publicado: (2014)

Management of Malignant Pericardial Effusion
por: Petrofsky, Mary
Publicado: (2014)

Low‐Dose Olanzapine Plus Granisetron and Dexamethasone for Carboplatin‐Induced Nausea and Vomiting in Patients with Thoracic Malignancies: A Prospective Multicenter Phase II Trial
por: Sakai, Chizuru, et al.
Publicado: (2021)

The Efficacy, Safety, and Side Effects of Intrapericardial Triamcinolone Treatment in Children with Post-surgical Pericardial Effusion: A Case Series
por: van der Werff, Manon H., et al.
Publicado: (2021)

Efficacy and safety of amrubicin monotherapy after atezolizumab plus carboplatin and etoposide in patients with relapsed small-cell lung cancer
por: Imai, Hisao, et al.
Publicado: (2022)

Real‐world data of atezolizumab plus carboplatin and etoposide in elderly patients with extensive‐disease small‐cell lung cancer
por: Shiono, Ayako, et al.
Publicado: (2022)

The Prognostic Impact of Pericardial Fluid Cytology in Malignant Pericardial Effusion
por: Sezenöz, Burak, et al.
Publicado: (2023)

Glasgow prognostic score predicts efficacy and prognosis in patients with advanced non‐small cell lung cancer receiving EGFR‐TKI treatment
por: Kasahara, Norimitsu, et al.
Publicado: (2020)

Intrapericardial Thymoma Presented as Pericardial Tamponade with Post-Operative Myasthenia Gravis
por: Tsai, Yueh-Hsun, et al.
Publicado: (2022)

Clinical impact of post‐progression survival on overall survival in elderly patients with extensive disease small‐cell lung cancer
por: Imai, Hisao, et al.
Publicado: (2016)

Course of postoperative relapse in non‐small cell lung cancer is strongly associated with post‐progression survival
por: Imai, Hisao, et al.
Publicado: (2021)

Efficacy of Intrapleural or Intrapericardial Injection of Single Bevacizumab in the Treatment of Lung Cancer-Mediated Malignant Effusion
por: He, Dongyun, et al.
Publicado: (2022)

Malignant pericardial effusion: sclerotherapy or local chemotherapy?
por: Lestuzzi, C, et al.
Publicado: (2009)

Survival post surgery for malignant pericardial effusion
por: Nguyen, Olivier, et al.
Publicado: (2011)

A case series of malignant pericardial effusion
por: Babu, Reshma S., et al.
Publicado: (2022)

Pericardial effusion
por: Marchiori, Edson, et al.
Publicado: (2021)

Effectiveness and Safety of EGFR-TKI Rechallenge Treatment in Elderly Patients with Advanced Non-Small-Cell Lung Cancer Harboring Drug-Sensitive EGFR Mutations
por: Yamada, Yutaka, et al.
Publicado: (2021)

Clinical Impact of Post-progression Survival in Patients with Locally Advanced Non-small Cell Lung Cancer After Chemoradiotherapy
por: Imai, Hisao, et al.
Publicado: (2022)

Post‐progression survival after atezolizumab plus carboplatin and etoposide as first‐line chemotherapy in small cell lung cancer has a significant impact on overall survival
por: Masubuchi, Ken, et al.
Publicado: (2022)

Pretreatment glasgow prognostic score predicts survival among patients administered first-line atezolizumab plus carboplatin and etoposide for small cell lung cancer
por: Wasamoto, Satoshi, et al.
Publicado: (2023)

Perspective of Immune Checkpoint Inhibitors in Thymic Carcinoma
por: Kaira, Kyoichi, et al.
Publicado: (2021)

Advanced Research on Immune Checkpoint Inhibitor Therapy
por: Imai, Hisao, et al.
Publicado: (2022)

Intermittent administration of atezolizumab with combined carboplatin and etoposide therapy for patients with extensive‑disease small cell lung cancer
por: Tsuda, Takeshi, et al.
Publicado: (2023)

Treatment of malignant pericardial effusion with (32)P-colloid
por: Dempke, W, et al.
Publicado: (1999)

Cannot write session to /tmp/vufind_sessions/sess_j7lbjgutpnlu8g68b8c5umeprm